Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM4VWXI)

Drug Name
[131I]-Metuximab Drug Info
Indication
Disease Entry ICD 11 Status REF
Liver cancer 2C12 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM4VWXI

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Basigin (BSG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gavilimomab DMH7CSQ Graft-versus-host disease 4B24 Phase 2/3 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Basigin (BSG) TT5UJWD BASI_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT00819650) A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection. U.S. National Institutes of Health.
2 Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):435-44.
3 National Cancer Institute Drug Dictionary (drug id 38221).